Literature DB >> 8109761

Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury.

W D Kovarik1, T S Mayberg, A M Lam, T L Mathisen, H R Winn.   

Abstract

The effect of succinylcholine (SCh) on intracranial pressure (ICP) was studied in 10 mechanically ventilated patients (Glasgow coma scale score 3-10, median 6) being treated for increased ICP in an intensive care unit. Mean arterial blood pressure (MAP), ICP, processed electroencephalogram (EEG), and mean middle cerebral artery blood flow velocity (V mca) were monitored. Baseline measurements after saline injection were obtained for 5 min. SCh (1 mg/kg) was administered intravenously and the above variables were monitored for 15 min. Neither saline nor SCh cause any significant change in cerebral perfusion pressure, MAP, V mca, EEG, or ICP. We conclude that in brain-injured patients, SCh did not alter cerebral blood flow velocity, cortical electrical activity, or ICP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8109761     DOI: 10.1213/00000539-199403000-00008

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

1.  Emergency Neurological Life Support: Airway, Ventilation, and Sedation.

Authors:  Venkatakrishna Rajajee; Becky Riggs; David B Seder
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 2.  Stroke in Pregnancy: A Focused Update.

Authors:  Eliza C Miller; Lisa Leffert
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

Review 3.  Emergency Neurological Life Support: Airway, Ventilation, and Sedation.

Authors:  David B Seder; Andy Jagoda; Becky Riggs
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 4.  In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review.

Authors:  M Clancy; S Halford; R Walls; M Murphy
Journal:  Emerg Med J       Date:  2001-09       Impact factor: 2.740

Review 5.  The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review.

Authors:  Filippo Sanfilippo; Cristina Santonocito; Tonny Veenith; Marinella Astuto; Marc O Maybauer
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

Review 6.  Emergency neurological life support: airway, ventilation, and sedation.

Authors:  David B Seder; Richard R Riker; Andy Jagoda; Wade S Smith; Scott D Weingart
Journal:  Neurocrit Care       Date:  2012-09       Impact factor: 3.210

Review 7.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 8.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 9.  Perioperative management of adult traumatic brain injury.

Authors:  Deepak Sharma; Monica S Vavilala
Journal:  Anesthesiol Clin       Date:  2012-06-13

10.  Perioperative management of traumatic brain injury.

Authors:  Parichat Curry; Darwin Viernes; Deepak Sharma
Journal:  Int J Crit Illn Inj Sci       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.